These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1977176)

  • 41. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
    Breese GR; Mueller RA
    Eur J Pharmacol; 1985 Jul; 113(1):109-14. PubMed ID: 2864260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
    Winkler JD; Weiss B
    J Pharmacol Exp Ther; 1989 May; 249(2):507-16. PubMed ID: 2566677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.
    Rubinstein M; Gershanik O; Stefano FJ
    Eur J Pharmacol; 1988 Apr; 148(3):419-26. PubMed ID: 2968273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Importance of D-2 mechanisms in the reversal of reserpine hypothermia in the mouse.
    Volterra G; Borsini F; Meli A
    J Pharm Pharmacol; 1988 Sep; 40(9):638-41. PubMed ID: 2907031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
    Shannon HE; Peters SC
    J Pharmacol Exp Ther; 1990 Nov; 255(2):549-53. PubMed ID: 2243341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907].
    Witkin JM; Dijkstra D; Levant B; Akunne HC; Zapata A; Peters S; Shannon HE; Gasior M
    J Pharmacol Exp Ther; 2004 Mar; 308(3):957-64. PubMed ID: 14711932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
    Vasse M; Chagraoui A; Protais P
    Eur J Pharmacol; 1988 Mar; 148(2):221-9. PubMed ID: 2897924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice.
    Ferré S; Herrera-Marschitz M; Grabowska-Andén M; Ungerstedt U; Casas M; Andén NE
    Eur J Pharmacol; 1991 Jan; 192(1):25-30. PubMed ID: 1828236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Responses to selective D-1 and D-2 agonists after repeated treatment with selective D-1 and D-2 antagonists.
    Gandolfi O; Dall'olio R; Vaccheri A; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Jun; 30(2):463-9. PubMed ID: 3262877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Similarity of clozapine and SCH 23390 in reserpinized rats suggests a common mechanism of action.
    Chipkin RE; Latranyi MB
    Eur J Pharmacol; 1987 Apr; 136(3):371-5. PubMed ID: 2886345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modification of seizures elicited by the benzodiazepine Ro 5-3663--a comparison with picrotoxin.
    File SE
    J Pharm Pharmacol; 1984 Dec; 36(12):837-40. PubMed ID: 6151978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopaminergic regulation of septohippocampal cholinergic neurons.
    Day JC; Fibiger HC
    J Neurochem; 1994 Dec; 63(6):2086-92. PubMed ID: 7964727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anticonvulsant effect of the hydroethanolic leaf extract of Psydrax subcordata (DC.) Bridson in murine models.
    Daanaa S; Abotsi WKM; Boakye-Gyasi E; Woode E
    J Ethnopharmacol; 2018 Mar; 213():384-394. PubMed ID: 29183747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased grooming behaviour is induced by apomorphine in mice treated with discriminant benzamide derivatives.
    Vasse M; Protais P
    Eur J Pharmacol; 1988 Oct; 156(1):1-11. PubMed ID: 2905270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anticonvulsant effect of striatal dopamine D2 receptor stimulation: dependence on cortical circuits?
    al-Tajir G; Starr MS
    Neuroscience; 1991; 43(1):51-7. PubMed ID: 1681459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.